Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Morosini Deborah Create: Alert

All | News | Filings
Date FiledTypeDescription
02/17/2022 4 Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Granted 90,000 options to buy @ $10.58, valued at $952.2k
12/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2021 4 Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Sold 28,351 shares @ $15.8711, valued at $450k
Sold 400 shares @ $16.425, valued at $6.6k
Exercised 28,751 options to buy @ $12.85, valued at $369.5k
07/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2020 4 Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 4 on Prelude Therapeutics Inc
Txns: Bought 444 shares @ $19, valued at $8.4k
09/24/2020 3 Morosini Deborah (EVP, Chief of Clinical Affairs) has filed a Form 3 on Prelude Therapeutics Inc

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy